首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1391972

生物工程人造皮膚市場：按產品類型、按應用、按最終用戶、按地區

Bioengineered Artificial Skin Market, By Product Type, By Application, By End User, By Geography

出版日期: 2023年11月02日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2023年全球生物工程人造皮膚市場規模將達33.2億美元，年複合成長率為16.9%，2030年將達99.2億美元。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	33.2億美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	16.90%	2030年市場規模預測	99.2億美元

圖 1. 按地區分類的全球生物工程人造皮膚市場

生物工程人造皮膚旨在承受表皮和真皮的功能，暫時使用，直到患者的皮膚屏障自然修復。生物工程皮膚用於解決長期深層皮膚傷口縫合過程而導致的嚴重疤痕。生物工程自體皮膚移植物源自於患者自身的皮膚細胞，並在少量皮膚或毛囊中生長或培養。生物工程人造皮膚專為重組皮膚附屬器、色素沉著和神經而設計。人造皮膚可以替代或用於替代皮膚的外層及其下面的較厚層（表皮和真皮）。最常用的商業性真皮細胞替代品由天然細胞外基質成分組成，分為兩類：去細胞細胞外基質和重建細胞外基質。

市場動態：

交通事故、燒傷和創傷相關事故數量增加，急慢性傷口發病率高（由於慢性病負擔增加和老年人口增加），公眾對各種皮膚治療的認知不斷提高，人造皮膚的需求不斷增加預計是推動全球生物工程人造皮膚市場成長的主要因素。

例如，2021 年 6 月，美國食品藥物管理局(FDA) 建議對涉及完整真皮層（剩餘深層皮膚層）的燒傷（也稱為深層燒傷）的臨床上需要手術干涉的成年患者進行手術干涉。核准StrataGraft 用於治療StrataGraft 是一種層級構造支架（細胞纖維母細胞）。

本研究的主要特點

本報告詳細分析了全球生物工程人造皮膚市場，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
它根據以下參數（例如公司亮點、產品系列、主要亮點、績效和策略）介紹了全球生物工程人造皮膚市場的主要企業。
該報告的見解將使行銷人員和經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略負責人資訊的決策。
全球生物工程人造皮膚市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進入者和財務分析師。
透過用於分析全球生物工程人造皮膚市場的各種策略矩陣，將促進相關人員的決策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 3.32 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	16.90%	2030 Value Projection:	US$ 9.92 Bn

Bioengineered skin is designed to undertake the functions of the epidermis and/or dermis as a temporary usage till the patient's skin barrier spontaneously repairs itself naturally. Bioengineered skin is used to address severe scars which represents the result of the closure process of extended and deep skin wounds. Bioengineered skin autografts are derived from the patient's own skin cells that are grown or cultured in small amounts of skin or hair follicles. Bioengineered artificial skin is designed for the reconstruction of skin appendages, pigmentation, and nerves. Artificial skin can replace or can be used to replace the outer layer of the skin or the thick layer just underneath it (epidermis and dermis). The most used commercially available acellular dermal substitutes are composed of natural extracellular matrix components and can be divided in two categories: decellularized extracellular matrices and reconstructed extracellular matrices.

Market Dynamics:

Rising number of road accidents, burns, and trauma-related incidents, high incidence of acute and chronic wounds (owing to the rise in burden of chronic diseases and growing geriatric population), increasing awareness among people about various skin treatments, and rise in demand for artificial skin are major factors expected to drive growth of the global bioengineered artificial skin market.

For instance, in June 2021, the U.S. Food and Drug Administration (FDA) approved StrataGraft for the treatment of adult patients with thermal burns, which contained intact dermal elements (remaining deep skin layers) for which surgical intervention is clinically indicated (also referred to as deep partial thickness burns). StrataGraft is produced from two kinds of human skin cells (keratinocytes and dermal fibroblasts) grown together to make a bi-layered construct (a cellularized scaffold).

Key features of the study:

This report provides in-depth analysis of the global bioengineered artificial skin market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global bioengineered artificial skin market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include AbbVie, Genoskin, Smith and Nephew Inc, Genzyme Biosurgery, Vericel Corporation, AROA BIOSURGERY LIMITED, Integra LifeSciences Corp, COOK BIOTECH, Molnlycke Health Care AB, Avita Medical, MiMedx Group, Inc. and Organogenesis Holdings Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global bioengineered artificial skin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bioengineered artificial skin market.

Detailed Segmentation:

By Product Type:
- Bilayered Bioengineered Artificial Skin
- Trilayered Bioengineered Artificial Skin
- Others
By Application:
- Chronic Wounds
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Pressure Ulcers
- Others
- Acute Wounds
- Burns
- Surgical Wounds
- Others
- Others
By End User:
- Hospitals
- Clinics
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles:
- AbbVie
- Genoskin
- Smith and Nephew Inc
- Genzyme Biosurgery
- Vericel Corporation
- AROA BIOSURGERY LIMITED
- Integra LifeSciences Corp
- COOK BIOTECH
- Molnlycke Health Care AB
- Avita Medical
- MiMedx Group, Inc.
- Organogenesis Holdings Inc

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions and Collaborations

4. Global Bioengineered Artificial Skin Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Bioengineered Artificial Skin Market, By Product Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Bilayered Bioengineered Artificial Skin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Trilayered Bioengineered Artificial Skin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Bioengineered Artificial Skin Market, By Application, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Chronic Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Diabetic Foot Ulcers
- Venous Leg Ulcers
- Pressure Ulcers
- Others
Acute Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Burns
- Surgical Wounds
- Others
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Bioengineered Artificial Skin Market, By End User, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global Bioengineered Artificial Skin Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
- U.S.
- Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub Region, 2018-2030,(US$ Bn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Company Profiles
- AbbVie
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Genoskin
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Smith and Nephew Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Genzyme Biosurgery.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Vericel Corporation.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- AROA BIOSURGERY LIMITED
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Integra LifeSciences Corp
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- COOK BIOTECH.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Molnlycke Health Care AB
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Avita Medical
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- MiMedx Group, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Organogenesis Holdings Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Analysts' Views

10. Section

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

2024 年生物工程技術世界市場報告

皮膚替代品和替代品的全球市場：市場規模和份額分析（按產品、類別、應用和最終用戶）、工業需求預測（截至 2030 年）

FAQ

生物工程人造皮膚市場：按產品類型、按應用、按最終用戶、按地區